Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type

R. Suzuki, J. Suzumiya, M. Yamaguchi, S. Nakamura, J. Kameoka, H. Kojima, M. Abe, T. Kinoshita, T. Yoshino, K. Iwatsuki, Y. Kagami, T. Tsuzuki, M. Kurokawa, K. Ito, K. Kawa, K. Oshimi

Research output: Contribution to journalArticle

162 Citations (Scopus)

Abstract

Background: Patients with natural killer (NK) cell neoplasms, aggressive NK cell leukemia (ANKL) and extranodal NK cell lymphoma, nasal type (ENKL), have poor outcome. Both diseases show a spectrum and the boundary of them remains unclear. The purpose of this study is to draw a prognostic model of total NK cell neoplasms. Patients and methods: We retrospectively analyzed 172 patients (22 with ANKL and 150 with ENKL). The ENKLs consisted of 123 nasal and 27 extranasal (16 cutaneous, 9 hepatosplenic, 1 intestinal and 1 nodal) lymphomas. Results: Complete remission rate for ENKL was 73% in stage I, but 15% in stage IV, which was consistent with that for ANKL (18%). The prognosis of ENKL was better than that of ANKL (median survival 10 versus 1.9 months, P < 0.0001) but was comparable when restricted to stage IV cases (4.0 months, P = 0.16). Multivariate analysis showed that four factors (non-nasal type, stage, performance status and numbers of extranodal involvement) were significant prognostic factors. Using these four variables, an NK prognostic index was successfully constructed. Four-year overall survival of patients with zero, one, two and three or four adverse factors were 55%, 33%, 15% and 6%, respectively. Conclusion: The current prognostic model successfully stratified patients with NK cell neoplasms with different outcomes.

Original languageEnglish
Pages (from-to)1032-1040
Number of pages9
JournalAnnals of Oncology
Volume21
Issue number5
DOIs
Publication statusPublished - Oct 22 2009

Keywords

  • CD16
  • Leukemia
  • Lymphoma
  • Natural killer cell
  • Prognosis

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type'. Together they form a unique fingerprint.

  • Cite this

    Suzuki, R., Suzumiya, J., Yamaguchi, M., Nakamura, S., Kameoka, J., Kojima, H., Abe, M., Kinoshita, T., Yoshino, T., Iwatsuki, K., Kagami, Y., Tsuzuki, T., Kurokawa, M., Ito, K., Kawa, K., & Oshimi, K. (2009). Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type. Annals of Oncology, 21(5), 1032-1040. https://doi.org/10.1093/annonc/mdp418